SCHEMBL1492958

SCHEMBL1492958

COc1cccc(C(C)NC(=O)Nc2ccc(-c3ccnc(C)c3)cc2)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 14/20 0.74
ROCK1 Q13464 13/20 0.74
PSEN1 P49768 5/20 0.64
PSEN2 P49810 5/20 0.64
APH1B Q8WW43 5/20 0.64
NCSTN Q92542 5/20 0.64
APH1A Q96BI3 5/20 0.64
PSENEN Q9NZ42 5/20 0.64
PRKG1 Q13976 3/20 0.59
CYP2C9 P11712 2/20 0.59
PRKACA P17612 2/20 0.59
CYP3A4 P08684 2/20 0.59
CYP2D6 P10635 2/20 0.59
PRKACG P22612 1/20 0.59
PRKACB P22694 1/20 0.59
AKT1 P31749 1/20 0.59
CHEK1 O14757 1/20 0.57
RPS6KA5 O75582 1/20 0.57
PRKCG P05129 1/20 0.57
CDK1 P06493 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27809653 1.00 ROCK2 (0.74) ROCK2ROCK1PSEN1PSEN2APH1B
SCHEMBL12650367 1.00 ROCK2 (0.74) ROCK2ROCK1PSEN1PSEN2APH1B
SCHEMBL12650393 0.90 ROCK2 (0.61) ROCK2ROCK1PSEN1PSEN2APH1B
SCHEMBL1492784 0.90 ROCK2 (0.61) ROCK2ROCK1PSEN1PSEN2APH1B
SCHEMBL1492754 0.89 PSEN1 (0.65) ROCK2ROCK1PSEN1PSEN2APH1B
SCHEMBL1492640 0.87 PSEN1 (0.72) ROCK2ROCK1PSEN1PSEN2APH1B
SCHEMBL7980383 0.87 PSEN1 (0.72) ROCK2ROCK1PSEN1PSEN2APH1B
SCHEMBL2183564 0.85 PSEN1 (0.86) ROCK2ROCK1PSEN1PSEN2APH1B
SCHEMBL3102020 0.85 ROCK1 (1.00) ROCK2ROCK1PRKG1CYP2C9PRKACA
SCHEMBL1492759 0.85 PSEN1 (0.58) ROCK2ROCK1PSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 ROCK2 4585/4885ROCK1 4259/4885PSEN1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.